Digital Channels And Pharmacy Integration Will Secure Long-Term Success

Key Takeaways

• Growth in digital channels, health offerings, and loyalty programs is enhancing customer engagement, retention, and overall sales momentum.
  
• Technology upgrades, private label expansion, and omnichannel integration are strengthening margins, operational efficiency, and competitive positioning.
  
• Margin and earnings growth are pressured by lagging e-commerce, rising labor costs, pharmacy mix headwinds, stiff competition, and slow realization of cost-saving initiatives.

Catalysts

Through its subsidiaries, operates in the food and drug retail industry in the United States.

• Accelerating growth in digital channels-including a 25% surge in e-commerce sales and a robust loyalty program-strongly positions Albertsons to capitalize on rising consumer demand for convenience and online grocery ordering, supporting higher future revenue and customer retention.
  
• Expansion and integration of pharmacy and health offerings (20% YoY growth), with enhanced digital cross-shopping, is increasing customer engagement, driving more frequent visits, and boosting overall basket size, directly benefiting top-line sales and increasing customer lifetime value.
  
• Modernization through technology investments-such as automation, AI-driven inventory/pricing, and centralized buying-are streamlining operations, reducing labor and supply chain costs, and positioning the company for long-term margin expansion and improved net earnings.
  
• Increasing penetration of private label and own brands (now at 25.7% of sales with a push to reach 30%+), along with targeted value investments, are driving higher-margin sales, deepening brand loyalty, and contributing to gross margin stabilization over time.
  
• Leveraging omnichannel capabilities and integrated digital experiences is enabling Albertsons to better compete for market share amidst urbanization and evolving health and wellness trends, which supports sustained same-store sales growth and overall top-line momentum.

Albertsons Companies Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming Albertsons Companies's revenue will grow by 2.1% annually over the next 3 years.
• Analysts are assuming Albertsons Companies's profit margins will remain the same at 1.2% over the next 3 years.
• Analysts expect earnings to reach $1.0 billion (and earnings per share of $2.13) by about July 2028, up from $954.3 million today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 16.4x on those 2028 earnings, up from 12.2x today. This future PE is lower than the current PE for the US Consumer Retailing industry at 22.3x.
• Analysts expect the number of shares outstanding to decline by 1.06% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.38%, as per the Simply Wall St company report.

Albertsons Companies Future Earnings Per Share Growth

Risks

• Albertsons' e-commerce business, though growing at 25% year-over-year, still lags industry peers in penetration, and reaching breakeven profitability remains a challenge; a persistent gap or inability to scale digital efficiently could result in continued pressure on net margins and limit overall earnings growth.
  
• Rising labor costs and ongoing union contract negotiations, as evidenced by 120,000 associates potentially affected in FY25 and a focus on improved wages and benefits, pose long-term risks of margin compression and higher SG&A expense, which could negatively impact net income.
  
• The grocery industry's highly competitive landscape-marked by sustained price investments, heavy promotional activity, and mounting pressure from mass, club, and discount value players (as well as non-traditional entrants like Amazon and Dollar General)-threatens to erode Albertsons' pricing power and market share, squeezing revenue growth and profitability.
  
• Growth is increasingly driven by the pharmacy segment (notably from high-priced GLP-1 drugs) rather than core grocery sales, but pharmacy often carries lower profitability and creates sustained mix headwinds for gross margin; over-reliance on this trend exposes future revenue and margin risk if pharmacy growth normalizes or reimbursement rates tighten.
  
• Despite technology and productivity investments, the company's near-term gross margin is under pressure as savings from supply chain efficiencies and national buying only gradually materialize, while aggressive investment in price and customer value is required to support unit growth; this mismatch could delay or dampen EBITDA and earnings growth in the face of inflation and secular consumer shifts towards value and healthier specialty foods.

Valuation

• The analysts have a consensus price target of $24.558 for Albertsons Companies based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $31.0, and the most bearish reporting a price target of just $19.0.
  
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $86.3 billion, earnings will come to $1.0 billion, and it would be trading on a PE ratio of 16.4x, assuming you use a discount rate of 8.4%.
  
• Given the current share price of $20.57, the analyst price target of $24.56 is 16.2% higher.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.